Literature DB >> 25117625

Nonhomologous end-joining repair plays a more important role than homologous recombination repair in defining radiosensitivity after exposure to high-LET radiation.

Akihisa Takahashi1, Makoto Kubo, Hongyu Ma, Akiko Nakagawa, Yukari Yoshida, Mayu Isono, Tatsuaki Kanai, Tatsuya Ohno, Yoshiya Furusawa, Tomoo Funayama, Yasuhiko Kobayashi, Takashi Nakano.   

Abstract

DNA double-strand breaks (DSBs) induced by ionizing radiation pose a major threat to cell survival. The cell can respond to the presence of DSBs through two major repair pathways: homologous recombination (HR) and nonhomologous end joining (NHEJ). Higher levels of cell death are induced by high-linear energy transfer (LET) radiation when compared to low-LET radiation, even at the same physical doses, due to less effective and efficient DNA repair. To clarify whether high-LET radiation inhibits all repair pathways or specifically one repair pathway, studies were designed to examine the effects of radiation with different LET values on DNA DSB repair and radiosensitivity. Embryonic fibroblasts bearing repair gene (NHEJ-related Lig4 and/or HR-related Rad54) knockouts (KO) were used and their responses were compared to wild-type cells. The cells were exposed to X rays, spread-out Bragg peak (SOBP) carbon ion beams as well as with carbon, iron, neon and argon ions. Cell survival was measured with colony-forming assays. The sensitization enhancement ratio (SER) values were calculated using the 10% survival dose of wild-type cells and repair-deficient cells. Cellular radiosensitivity was listed in descending order: double-KO cells > Lig4-KO cells > Rad54-KO cells > wild-type cells. Although Rad54-KO cells had an almost constant SER value, Lig4-KO cells showed a high-SER value when compared to Rad54-KO cells, even with increasing LET values. These results suggest that with carbon-ion therapy, targeting NHEJ repair yields higher radiosensitivity than targeting homologous recombination repair.

Entities:  

Mesh:

Year:  2014        PMID: 25117625     DOI: 10.1667/RR13782.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  21 in total

1.  TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation.

Authors:  Younghyun Lee; Shigeaki Sunada; Hirokazu Hirakawa; Akira Fujimori; Jac A Nickoloff; Ryuichi Okayasu
Journal:  Mol Cancer Ther       Date:  2016-11-09       Impact factor: 6.261

Review 2.  Combined Treatment Modalities for High-Energy Proton Irradiation: Exploiting Specific DNA Repair Dependencies.

Authors:  Simon Deycmar; Martin Pruschy
Journal:  Int J Part Ther       Date:  2018-09-21

Review 3.  Evaluating biomarkers to model cancer risk post cosmic ray exposure.

Authors:  Deepa M Sridharan; Aroumougame Asaithamby; Steve R Blattnig; Sylvain V Costes; Paul W Doetsch; William S Dynan; Philip Hahnfeldt; Lynn Hlatky; Yared Kidane; Amy Kronenberg; Mamta D Naidu; Leif E Peterson; Ianik Plante; Artem L Ponomarev; Janapriya Saha; Antoine M Snijders; Kalayarasan Srinivasan; Jonathan Tang; Erica Werner; Janice M Pluth
Journal:  Life Sci Space Res (Amst)       Date:  2016-05-21

Review 4.  Strategies to Enhance Radiosensitivity to Heavy Ion Radiation Therapy.

Authors:  Younghyun Lee; Ryuichi Okayasu
Journal:  Int J Part Ther       Date:  2018-09-21

Review 5.  Opportunities and challenges of radiotherapy for treating cancer.

Authors:  Dörthe Schaue; William H McBride
Journal:  Nat Rev Clin Oncol       Date:  2015-06-30       Impact factor: 66.675

6.  The major DNA repair pathway after both proton and carbon-ion radiation is NHEJ, but the HR pathway is more relevant in carbon ions.

Authors:  Ariungerel Gerelchuluun; Eri Manabe; Takaaki Ishikawa; Lue Sun; Kazuya Itoh; Takeji Sakae; Kenshi Suzuki; Ryoichi Hirayama; Aroumougame Asaithamby; David J Chen; Koji Tsuboi
Journal:  Radiat Res       Date:  2015-03-04       Impact factor: 2.841

Review 7.  Proton therapy for locally advanced non-small cell lung cancer.

Authors:  Olsi Gjyshi; Zhongxing Liao
Journal:  Br J Radiol       Date:  2019-08-20       Impact factor: 3.039

8.  The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining.

Authors:  Younghyun Lee; Huizi Keiko Li; Aya Masaoka; Shigeaki Sunada; Hirokazu Hirakawa; Akira Fujimori; Jac A Nickoloff; Ryuichi Okayasu
Journal:  Radiother Oncol       Date:  2016-09-22       Impact factor: 6.280

9.  Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams.

Authors:  M Kano; K Matsushita; B Rahmutulla; S Yamada; H Shimada; S Kubo; T Hiwasa; H Matsubara; F Nomura
Journal:  Gene Ther       Date:  2015-08-04       Impact factor: 5.250

10.  Nonhomologous End Joining Is More Important Than Proton Linear Energy Transfer in Dictating Cell Death.

Authors:  Scott J Bright; David B Flint; Sharmistha Chakraborty; Conor H McFadden; David S Yoon; Lawrence Bronk; Uwe Titt; Radhe Mohan; David R Grosshans; Pavel Sumazin; Simona F Shaitelman; Aroumougame Asaithamby; Gabriel O Sawakuchi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-08-16       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.